A rare case of primary hyperaldosteronism associated with chronic kidney disease-difficulties in diagnosis and treatment

Introduction: Simultaneous fractures in the neck of femur on the one side and contralateral intertrochanteric fracture of the femur with only trivial injury are among rarest injuries. Fracture neck of femur or intertrochanteric fracture either isolated or in combination such as simultaneous bilateral fracture neck of femur and simultaneous bilateral intertrochanteric fractures are relatively commonly reported in literature. Herein, we report a very rare case of a young female with chronic kidney disease who presented with simultaneous fractures neck of femur on the one side and contralateral intertrochanteric fracture of femur after a fall from standing height. Case Report: A 41-year-old female with chronic kidney disease from the past 5 years presented to us with severe pain at both hip and inability to stand after a fall from standing height. Clinical examination and investigations were done. She suffered fracture neck of femur on the right side and intertrochanteric fracture femur on the left side. Single stage fixation of both these fractures by two different methods was done successfully after optimization of her medical condition with multidisciplinary approach. She was advised weight bearing according to fixation method used and progress of fracture union. She regained her preoperative walking status gradually in 6 months. Conclusion: Simultaneous fractures in the neck of femur on the one side and intertrochanteric fracture of the femur on the other side are very rare presentation and can happen in patients with primary or secondary bone disease. Multidisciplinary team effort is needed for overall effective management and prompt surgical treatment can help achieve favorable outcome. Keywords: Simultaneous, fracture neck of femur, intertrochanteric fracture femur.

Download Full-text

A Rare Case of Aeromonas Hydrophila Catheter Related Sepsis in a Patient with Chronic Kidney Disease Receiving Steroids and Dialysis: A Case Report and Review of Aeromonas Infections in Chronic Kidney Disease Patients

Case Reports in Nephrology ◽

10.1155/2013/735194 ◽

2013 ◽

Vol 2013 ◽

pp. 1-5 ◽

Cited By ~ 3

Author(s):

Muhammad Abdul Mabood Khalil ◽

Abdur Rehman ◽

Waqar Uddin Kashif ◽

Manickam Rangasami ◽

Jackson Tan

Keyword(s):

Chronic Kidney Disease ◽

Case Report ◽

Kidney Disease ◽

Aeromonas Hydrophila ◽

Rare Case ◽

Oral Prednisolone ◽

Dialysis Catheter ◽

Peripheral Vein ◽

Double Lumen ◽

Methyl Prednisolone

Aeromonas hydrophila (AH) is an aquatic bacterium. We present a case of fifty-five-year-old gentleman with chronic kidney disease (CKD) due to crescentic IgA nephropathy who presented to us with fever. He was recently pulsed with methyl prednisolone followed by oral prednisolone and discharged on maintenance dialysis through a double lumen dialysis catheter. Blood culture from peripheral vein and double lumen dialysis catheter grew AH. We speculate low immunity due to steroids and uremia along with touch contamination of dialysis catheter by the patient or dialysis nurse could have led to this rare infection. Dialysis catheter related infection by AH is rare. We present our case here and take the opportunity to give a brief review of AH infections in CKD patients.

Download Full-text

5. Diagnosis and Treatment for Patients with Chronic Kidney Disease.

Nihon Naika Gakkai Zasshi ◽

10.2169/naika.100.777 ◽

2011 ◽

Vol 100 (3) ◽

pp. 777-783

Author(s):

Hiromichi Suzuki

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Diagnosis And Treatment

Download Full-text

Report of a rare case of congenital mitral valve prolapse with chronic kidney disease––reconsidered genotype–phenotypic correlations

Molecular Genetics & Genomic Medicine ◽

10.1002/mgg3.1558 ◽

2020 ◽

Author(s):

Liping Sun ◽

Xinzhou Zhang

Keyword(s):

Chronic Kidney Disease ◽

Mitral Valve ◽

Kidney Disease ◽

Mitral Valve Prolapse ◽

Rare Case ◽

Phenotypic Correlations

Download Full-text

Chronic kidney disease-mineral bone disorder

British Journal of Hospital Medicine ◽

10.12968/hmed.2019.80.12.c180 ◽

2019 ◽

Vol 80 (12) ◽

pp. C180-C183

Author(s):

Thomas Cronin ◽

Mohammed Abdelmahamoud ◽

Derek Falls ◽

Katherine Punshon ◽

Jamie Willows ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Diagnosis And Treatment ◽

Advanced Chronic Kidney Disease ◽

Mineral Bone Disorder ◽

Basic Understanding ◽

Bone Disorder ◽

Outpatient Settings

Chronic kidney disease-mineral bone disorder is typically seen in patients with advanced chronic kidney disease. It is managed primarily by renal physicians, but non-renal physicians are also likely to encounter patients undergoing treatment for this condition in both inpatient and outpatient settings so a basic understanding of the principles may be helpful. This article covers the fundamentals of the pathophysiology, diagnosis and treatment of chronic kidney disease-mineral bone disorder.

Download Full-text

Parathyroid Hormone Fragments: New Targets for the Diagnosis and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder

BioMed Research International ◽

10.1155/2018/9619253 ◽

2018 ◽

Vol 2018 ◽

pp. 1-14 ◽

Cited By ~ 1

Author(s):

Huimin Chen ◽

Xiaxia Han ◽

Ying Cui ◽

Yangfan Ye ◽

Yogendranath Purrunsing ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Parathyroid Hormone ◽

Kidney Disease ◽

Vital Role ◽

Diagnosis And Treatment ◽

Mineral And Bone Disorder ◽

Bone Disorder ◽

Calcium Phosphorus ◽

Further Development ◽

Made In

As a common disorder, chronic kidney disease (CKD) poses a great threat to human health. Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a complication of CKD characterized by disturbances in the levels of calcium, phosphorus, parathyroid hormone (PTH), and vitamin D; abnormal bone formation affecting the mineralization and linear growth of bone; and vascular and soft tissue calcification. PTH reflects the function of the parathyroid gland and also takes part in the metabolism of minerals. The accurate measurement of PTH plays a vital role in the clinical diagnosis, treatment, and prognosis of patients with secondary hyperparathyroidism (SHPT). Previous studies have shown that there are different fragments of PTH in the body’s circulation, causing antagonistic effects on bone and the kidney. Here we review the metabolism of PTH fragments; the progress being made in PTH measurement assays; the effects of PTH fragments on bone, kidney, and the cardiovascular system in CKD; and the predictive value of PTH measurement in assessing the effectiveness of parathyroidectomy (PTX). We hope that this review will help to clarify the value of accurate PTH measurements in CKD-MBD and promote the further development of multidisciplinary diagnosis and treatment.

Download Full-text